These 3 stocks have gained more than 30% over the past month
The market has been rewarding two completely different groups of companies in recent weeks. Those that supply the physical infrastructure for artificial intelligence, and those where a major regulatory or clinical decision is approaching. Three names from this analysis have gained over 30% in the past month, but each for a different reason and with a different risk profile. We looked at what is really behind the move, where ordinary screeners distort valuation, and what each company must deliver to justify today's multiples.

Key points
Three stocks gained over 30% in a few weeks. But behind similar price moves are three completely different paths.
A price increase does not necessarily mean equally strong business growth. With volatile names, the choice of start date can dramatically change the resulting values.
Classic screeners fail for all three stocks. P/E, cash flow, and beta can lead an investor to a completely different conclusion than reality.
The market today is not just pricing in results, but above all future scenarios. The difference between what is already priced in and what companies actually deliver will be decisive.
What must happen for the stocks to justify a gain of over 30%? The answer is completely different for each company, and for one, a single day could decide.
August and September 2026 brought a shift of capital on the US market toward smaller and mid-cap names tied to the AI investment cycle. The three companies that gained over 30% during this period are not linked by sector or size. They are linked by the fact that for each of them, within a few weeks, what the market considers a likely scenario changed. For two, it was numbers in results and outlook; for the third, important data.
For a retail investor, this is precisely the riskiest moment. A name after a 30 to 50% gain appears in all screeners and headlines, but the difference between a rally based on real cash flow and a rally that is merely a repricing of expectations cannot be seen from the chart.